Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/17/2014US8754064 Milk oligosaccharide for stimulating the immune system
06/17/2014US8754063 Use of oligouronates for treating mucus hyperviscosity
06/17/2014US8754057 Inhibition of apoptosis-specific eIF-5A(eIF-5A1″) with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics
06/17/2014US8754054 Antibacterial compounds, methods of making them, and uses thereof
06/17/2014US8754052 Treatment of nephrolithiasis and urolithiasis using 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG)
06/17/2014US8754041 Method of removing E. coli bacteria from an aqueous solution
06/17/2014US8754037 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
06/17/2014US8754032 Concomitant pharmaceutical agents and use thereof
06/17/2014US8754029 Ophthalmic composition
06/17/2014US8754009 Active compound combinations
06/17/2014US8753697 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
06/17/2014US8753683 Delivery of a bioactive material
06/17/2014US8753682 Dual release oral tablet compositions of dexlansoprazole
06/17/2014US8753681 Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
06/17/2014US8753679 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
06/17/2014US8753674 Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
06/17/2014US8753673 Liposome composition for delivery of a therapeutic agent to eyes
06/17/2014US8753667 Multi-layered gradient vaginal ring
06/17/2014US8753665 Controlled delivery system
06/17/2014US8753663 Drug eluting coatings for medical implants
06/17/2014US8753659 Drug delivery from stents
06/17/2014US8753658 Bait materials, pest monitoring devices and other pest control devices that include polyurethane foam
06/17/2014US8753654 Substantially anhydrous compositions for personal care
06/17/2014US8753633 Human antibodies that bind human TNFα
06/17/2014US8753620 Injectable bulking compositions
06/17/2014US8753619 Tissue adhesives and sealants and methods for their use
06/17/2014US8753611 Sublingual buccal effervescent
06/17/2014CA2764314C Process for production of optically active amine derivatives
06/17/2014CA2725014C Inhibitors of pi3 kinase
06/17/2014CA2716757C Kit, composition, product or medicament for treating cognitive impairment
06/17/2014CA2714942C Stabilized single-liquid pharmaceutical composition containing docetaxel
06/17/2014CA2699986C Anti-infective pyrimidines and uses thereof
06/17/2014CA2690828C Composition containing microrna-21 inhibitor for enhancing radiation sensitivity
06/17/2014CA2678907C Modulators of pharmacokinetic properties of therapeutics
06/17/2014CA2665490C Method for treatment of macular degeneration
06/17/2014CA2659599C Amino alcohol derivative and immunosuppressive agent having same as an active ingredient
06/17/2014CA2659382C Pharmaceutical suspensions comprising phenylephrine and method of preparation
06/17/2014CA2656566C Dihydrofuro pyrimidines as akt protein kinase inhibitors
06/17/2014CA2650716C Hydroxybutyrate and poly-hydroxybutyrate as components of animal feed or feed additives
06/17/2014CA2646333C Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
06/17/2014CA2644649C Cyclic-alkylaminederivatives as inhibitors of the interaction between mdm2 and p53
06/17/2014CA2643235C Use of rasagiline for the treatment of multiple system atrophy
06/17/2014CA2637365C Injectable viscous medicinal preparation comprising ethanol and an x-ray opaque fat-soluble compound
06/17/2014CA2635531C Multicyclic amino acid derivatives and methods of their use
06/17/2014CA2634721C Triazolopyridazines as tyrosine kinase modulators
06/17/2014CA2630273C Heterocyclylalkyl derivatives as inhibitors of histone deacetylase
06/17/2014CA2628225C A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
06/17/2014CA2626028C Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders
06/17/2014CA2620389C Compositions and methods for preparation of poorly water soluble drugs with increased stability
06/17/2014CA2607419C Granular preparation containing biguanide compound
06/17/2014CA2604617C Composition containing anti-dementia drug
06/17/2014CA2603347C Oil-in-water emulsions of lignans that exhibit improved absorption rate
06/17/2014CA2601979C 2,3 substituted pyrazine sulfonamides
06/17/2014CA2596714C Method for treating gefitinib resistant cancer
06/17/2014CA2595848C Erastin and erastin binding proteins, and uses thereof
06/17/2014CA2583409C Phospho-indoles as hiv inhibitors
06/17/2014CA2580247C Process for the preparation of enantiomers of amidoacetonitrile compounds from their racemates
06/17/2014CA2575587C Carrier for enteral administration
06/17/2014CA2564436C Use of chondroitin sulphate e (cs-e ) for the treatment of disease or conditions related to collagen fibril formation.
06/17/2014CA2535063C Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease
06/17/2014CA2507607C Heterocyclic compounds, their preparation and their use as medication, specifically as anti-bacterials and inhibitors of beta-lactamases
06/17/2014CA2505469C Drug delivery device comprising a bilayered polymeric coating having a cell cycle inhibitor that acts selectively at the g1 phase of the cell cycle incorporated into the first polymer coating layer
06/17/2014CA2451740C Composition comprising wenguanguo extracts, methods for preparing same and uses thereof
06/12/2014WO2014089571A1 Anticancer compounds
06/12/2014WO2014089570A1 Combinations of a pi3k/akt inhibitor compound with an her3/egfr inhibitor compound and use thereof in the treatment of a hyperproliferative disorder
06/12/2014WO2014089547A2 Sport voting system
06/12/2014WO2014089546A1 Targeted covalent probes and inhibitors of proteins containing redox-sensitive cysteines
06/12/2014WO2014089526A1 Treatment for chronic kidney disease
06/12/2014WO2014089495A1 Diazole lactams
06/12/2014WO2014089483A1 Methods and compositions for treatment of cancer
06/12/2014WO2014089482A1 Polymorph forms of desazadesferrithiocin analogs
06/12/2014WO2014089450A1 Specific inhibitors of cdk3
06/12/2014WO2014089449A1 Composition and method for treating neuronal ceroid lipofuscinosis
06/12/2014WO2014089417A2 Physical context and cookies
06/12/2014WO2014089416A1 Compositions comprising anti-cd38 antibodies and lenalidomide
06/12/2014WO2014089381A1 Topical preparation for pain relief
06/12/2014WO2014089379A1 Compounds useful as inhibitors of atr kinase
06/12/2014WO2014089378A1 Thienopyridine derivatives for the treatment and prevention of dengue virus infections
06/12/2014WO2014089365A1 Beta-lactamase inhibitors
06/12/2014WO2014089364A1 Histone demethylase inhibitors
06/12/2014WO2014089324A1 Substituted cyclic compounds and methods of use
06/12/2014WO2014089280A1 Alkynyl compounds and methods of use
06/12/2014WO2014089269A1 Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
06/12/2014WO2014089226A1 Antibacterial compounds targeting isoprenoid biosynthesis
06/12/2014WO2014089140A1 Process for making reverse transcriptase inhibitors
06/12/2014WO2014089067A2 Use of capsazepine and analogs thereof to treat cancer
06/12/2014WO2014089048A1 Treatment of cancer with heterocyclic inhibitors of glutaminase
06/12/2014WO2014089029A1 Activation of innate immunity by mirna for cancer and infection treatment
06/12/2014WO2014089019A1 Methods and compositions for treating vasomotor symptoms
06/12/2014WO2014089004A1 Methods for treating 5-fluorouracil prodrug non-responsive cancer patients
06/12/2014WO2014088983A1 Regioselective n-2 arylation of indazoles
06/12/2014WO2014088838A1 Finafloxacin suspension compositions
06/12/2014WO2014088785A1 Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
06/12/2014WO2014088657A1 C20'-urea derivatives of vinca alkaloids
06/12/2014WO2014088641A1 Methods for restoration of histamine balance
06/12/2014WO2014088629A1 Methods and compositions for treating hiv-associated diarrhea
06/12/2014WO2014088519A1 Compounds including map kinase interacting kinases 1 and 2 (mnk1 and mnk2) modulators and abl and abl (t315i) inhibitors, and uses thereof
06/12/2014WO2014088444A1 Dispersion of solid lipid nano-particles and compositions on the basis thereof
06/12/2014WO2014088435A1 Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-os-mal-iii
06/12/2014WO2014088434A1 Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-ds-mal-iii
1 ... 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 ... 7860